Financial insights of PHGE

MyFinsight

For the quarter ending 2026-03-31.

Income Statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Research and development (r&d) expenses, net	-315	12,496*	6,122	5,014
General and administrative expenses	1,611	2,379*	2,414	2,419
Gain from early lease termination	-	737*	-	-
Ipr&d impairment	-	2,961*	-	-
Other long-lived assets impairment	-	413*	-	-
Operating loss	-1,296	-17,511*	-8,536	-7,433
Other expenses (income)	147	-24*	24	-70
Income from change in fair value of warrants	-	-4,959*	730	-1,498
Finance expense , net	-	-812*	84	-25
Net gain from deconsolidation of subsidiary	1,860	-	-	-
Interest expenses	192	5*	5	5
Day one loss upon entering transaction	5,226	-	-	-
Loss (income) from change in derivatives financial instruments measured at fair value	-14,056	-	-	-
Finance expense, net	-377	-	-	-
Net loss before tax	-19,140	-13,394*	-9,163	-6,035
Tax expenses	-	0*	3	2
Net loss	-19,140	-13,394	-9,166	-6,037

Basic EPS	7.38	0.232	0.29	0.19
Diluted EPS	7.38	0.232	0.29	0.19
Basic Average Shares	2,603,807	-57,814,837	31,399,552	31,308,396
Diluted Average Shares	2,603,807	-57,814,837	31,399,552	31,308,396

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.